Tsuyoshi Takahara : Citation Profile

Senshu University

1

H index

0

i10 index

2

Citations

RESEARCH PRODUCTION:

3

Articles

6

Papers

RESEARCH ACTIVITY:

   11 years (2013 - 2024). See details.
   Cites by year: 0
   Journals where Tsuyoshi Takahara has often published
   Relations with other researchers
   Recent citing documents: 1.    Total self citations: 0 (0 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pta527
   Updated: 2026-02-21    RAS profile: 2025-10-11    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Ishida, Junichiro (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Tsuyoshi Takahara.

Is cited by:

LEVAGGI, ROSELLA (2)

Cites to:

Matsumura, Toshihiro (6)

Mauleon, Ana (3)

Crainich, David (3)

Ellis, Randall (3)

Matsushima, Noriaki (3)

Sloan, Frank (3)

LELEU, Hervé (3)

Higashida, Keisaku (2)

Lambertini, Luca (2)

Hattori, Keisuke (2)

Xu, Lili (2)

Main data

Where Tsuyoshi Takahara has published?

Working Papers Series with more than one paper published# docs
ISER Discussion Paper / Institute of Social and Economic Research, The University of Osaka4
MPRA Paper / University Library of Munich, Germany2

Recent works citing Tsuyoshi Takahara (2025 and 2024)

YearTitle of citing document
2024Spatial Competition Models in Health Care Markets: A Review. (2024). LEVAGGI, ROSELLA. In: Review of Industrial Organization. RePEc:kap:revind:v:65:y:2024:i:3:d:10.1007_s11151-024-09978-6.

Full description at Econpapers || Download paper

Works by Tsuyoshi Takahara:

YearTitleTypeCited
2024Should product‐specific advertisement be regulated in pharmaceutical markets? In: Journal of Public Economic Theory.
[Full Text][Citation analysis]		article0
2022Should Product-Specific Advertisement be Regulated in Pharmaceutical Markets?.(2022) In: ISER Discussion Paper.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
2013Patient Dumping, Outlier Payment, and Optimal Healthcare Payment Policy under Asymmetric Information In: ISER Discussion Paper.
[Full Text][Citation analysis]		paper0
2014Patient Dumping, Outlier Payments, and Optimal Healthcare Payment Policy under Asymmetric Information.(2014) In: ISER Discussion Paper.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
2016Patient dumping, outlier payments, and optimal healthcare payment policy under asymmetric information.(2016) In: Health Economics Review.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		article
2019Advertising Regulations in Pharmaceutical Markets: Product Versus Enlightenment In: ISER Discussion Paper.
[Full Text][Citation analysis]		paper0
2022Quality competition, location choice, and ownership conversion in the healthcare market In: Economic Modelling.
[Full Text][Citation analysis]		article2
2023Designing the report card content for healthcare payment reduction In: MPRA Paper.
[Full Text][Citation analysis]		paper0
2024Evaluating Policy Interventions for Audit Quality Improvement: Market Competition versus Audit Firm Separation In: MPRA Paper.
[Full Text][Citation analysis]		paper0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated December, 22 2025. Contact: CitEc Team